Alex Aliper ^UDM

Alex Aliper serves as the President of Insilico Medicine, a biotech research firm in Hong Kong SAR specializing in the use of artificial intelligence for drug discovery and aging research. His prior role as a research associate at the Center for Pediatric Hematology, Oncology, and Immunology provided him with substantial scientific experience. Under his leadership, Insilico Medicine is making strides in identifying novel biomarkers and targets for the development of treatments for aging and age-related diseases.